纳诺生物科技

最新新闻

• Guggenheim Maintains Nanobiotix(NBTX.US) With Buy Rating, Maintains Target Price $64
  \u5e02\u573a\u8d44\u8baf · 2026/9/25
• 评级变动
  Guggenheim Maintains Nanobiotix(NBTX.US) With Buy Rating, Cuts Target Price to $8
  \u5e02\u573a\u8d44\u8baf · 2025/4/5
• 评级变动
  TD Cowen Initiates Nanobiotix(NBTX.US) With Buy Rating
  \u5e02\u573a\u8d44\u8baf · 2026/2/6
• Guggenheim Initiates Nanobiotix(NBTX.US) With Buy Rating, Announces Target Price $64
  \u5e02\u573a\u8d44\u8baf · 2026/9/15
• Guggenheim Maintains Nanobiotix(NBTX.US) With Buy Rating, Raises Target Price to $36
  \u5e02\u573a\u8d44\u8baf · 2026/4/2
• 评级变动
  Guggenheim Initiates Nanobiotix(NBTX.US) With Buy Rating, Announces Target Price $12
  \u5e02\u573a\u8d44\u8baf · 2024/8/28
• Earnings Call Summary | Nanobiotix(NBTX.US) Q4 2025 Earnings Conference
  \u5e02\u573a\u8d44\u8baf · 2026/4/2
• 评级变动
  Leerink Partners Maintains Nanobiotix(NBTX.US) With Buy Rating, Raises Target Price to $14
  \u5e02\u573a\u8d44\u8baf · 2025/9/19
• Guggenheim Maintains Nanobiotix(NBTX.US) With Buy Rating, Maintains Target Price $36
  \u5e02\u573a\u8d44\u8baf · 2026/5/5
• 评级变动
  Leerink Partners Maintains Nanobiotix(NBTX.US) With Buy Rating, Raises Target Price to $37
  \u5e02\u573a\u8d44\u8baf · 2026/4/1
• 评级变动
  Leerink Partners Maintains Nanobiotix(NBTX.US) With Buy Rating, Announces Target Price $9
  \u5e02\u573a\u8d44\u8baf · 2025/5/24
• 评级变动
  Guggenheim Maintains Nanobiotix(NBTX.US) With Buy Rating, Maintains Target Price $8
  \u5e02\u573a\u8d44\u8baf · 2025/7/9
• 评级变动
  TD Cowen Maintains Nanobiotix(NBTX.US) With Buy Rating
  \u5e02\u573a\u8d44\u8baf · 2026/4/2
• 评级变动
  Leerink Partners Maintains Nanobiotix(NBTX.US) With Buy Rating, Raises Target Price to $24
  \u5e02\u573a\u8d44\u8baf · 2025/10/1
• 评级变动
  UBS Initiates Nanobiotix(NBTX.US) With Hold Rating, Announces Target Price $3.5
  \u5e02\u573a\u8d44\u8baf · 2025/4/6

新闻标题为自动聚合内容，未经我们团队独立核实或编辑。